Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

The TAPUR trail is inspiring similar initiatives across the world

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 09.07.18
Views: 126

Dr Richard Schilsky - American Society Of Clinical Oncology, USA

Dr Schilsky speaks with ecancer at the 2018 WIN symposium about the TAPUR trial which is an ASCO trial of which there may be an inspired WIN version.

The goal of the TAPUR trial is to learn about signals of activity for marketed drugs used off label, in tumour types which have a specific genomic alteration.

The potential of universal trials similar to the TAPUR trial could lead to a lot of useful data sharing.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.

Related videos

follow us

ONJ e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence